""

  • : 363


(RUS)◊ .: 10 .
(RUS)◊ .: 25 .
(RUS)◊ - /. . . : . 100
(RUS)◊ - /. . . : . 100
- (RUS)◊ - /. . . : . 100
MEDICAL 15 " PoiskLekarstv.ru" (RUS):
® - (RUS)◊ /. . 640 +1 /1 : 15 30
® - (RUS)◊ 500 +10 +1 /1 : 15 30
® - (RUS)◊ /. . 500 +30 /1 : 15 30
®NYCOMED AUSTRIA (AUT)◊ /. . 20%: 20 , 30 , 50 100
®NYCOMED AUSTRIA (AUT)◊ /. . 5%: 20 , 30 , 50 100
®NYCOMED AUSTRIA (AUT)◊ /. . 5%: 20 , 30 , 50 100
(RUS)◊ 800 /1 : . 50 100
ESPARMA (DEU)◊ /. .: 20 , 30 , 50 100
PHARMACEUTICAL WORKS JELFA (POL)◊ /. . 2%: 15 40 , 400
(RUS)◊ /. .: . 5
- (RUS)◊ /. .: . 5
- (RUS)◊ /. .: . 5
(RUS)◊ /. .: . 5
- (RUS)◊ /. .: . 2.5 , 5 , 6 , 15 20 10 .
Laboratoires GALDERMA (FRA)◊ /. . 2.5%: 40
Laboratoires GALDERMA (FRA)◊ /. . 5%: 40
Laboratoires GALDERMA (FRA)◊ /. . 10%: 40
®SmithKline Beecham Pharmaceuticals (GBR) 2%: 15
-- (RUS)◊ /. . 50 : .
-- (RUS)◊ /. . 100 : .
®SANDOZ (AUT)◊ /. . 250 +5000 /1 : 20
®MERCK (AUT)◊ /. . 250 +5000 /1 : 20
®Pharmazeutische Fabrik MONTAVIT (AUT)◊ /. . 250 +5000 /1 : 10
®SANDOZ (AUT)◊ /. . 250 +5000 /1 : 10
®BELUPO Pharmaceuticals & Cosmetics (HOR)◊ /. . 500 +1 /1 : 15 30
®BELUPO Pharmaceuticals & Cosmetics (HOR)◊ /. . 500 +1 /1 : 15 30
®BELUPO Pharmaceuticals & Cosmetics (HOR)◊ /. . 500 +30 /1 : 30
® BELUPO Pharmaceuticals & Cosmetics (HOR)◊ - /. . 500 +20 /1 : .-. 50
-®PFIZER ILACLARI (TUR)◊ /. . 150 +100 /1 : 35
-® PFIZER ILACLARI (TUR)◊ /. . 280 +100 /1 : 35
®FAMAR NEDERLAND (NID)◊ 2.5%: . 200 400
®BAYER CONSUMER CARE (CHE)◊ 2.5%: . 200 400
®BAYER CONSUMER CARE (CHE)◊ 5%: 3.5 , 30 100
®GP GRENZACH PRODUKTIONS (DEU)◊ 5%: 3.5 , 30 100
®BAYER CONSUMER CARE (CHE)◊ 5%: 3.5 , 30 100
®GP GRENZACH PRODUKTIONS (DEU)◊ 5%: 3.5 , 30 100
® BAYER CONSUMER CARE (CHE)◊ /. . 50 +5 /1 : 3.5 , 30 100
® GP GRENZACH PRODUKTIONS (DEU)◊ /. . 50 +5 /1 : 3.5 , 30 100
(RUS)◊ /. . 25 +4 /1 : 15 , 20 25
-GlaxoSmithKline Pharmaceuticals (IND)◊ /. . 1 +30 /1 : 20
® (RUS)◊ / . 5%: 40 , 40
® (RUS)◊ / . 10%: 40 , 40
® (RUS)◊ 20%: 40 , 40
- - (RUS)◊ /. . 20.2 +3.9 /100 : 35
--- (RUS)◊ /. . 20.2 +3.9 /100 : 25 , 40
- (RUS)◊ /. . 20.2 +3.9 /100 : 25
STIEFEL LABORATORIES (IRELAND) (IRL) /. . 0.15%: 5 10
® LEK d.d. (SLO)◊ /. . 10 +100 : 50
®- (RUS)◊ /. . 20 +50 +2.5 /1 : 30 40
/ (RUS), , , , , , , , , , ,
(RUS)◊ 50 : .
(BLR)◊ /. .: 25
® TALLINN PHARMACEUTICAL COMPANY (EST)◊ /. .: 30 50
®SOPHARMA (BLG)◊ /. . . 120 /1 : 45
(RUS)◊ /. . 2 +10 /100 : 40 50
(RUS) /. . 0.1%: 10 15
(RUS) /. . 0.1%: 15
(BLR) /. . 0.1%: 25
- (RUS) 0.1%: 15
(RUS)◊ /. . 1000 /1 : 30, 50 100
- (RUS)◊ /. . 100 +40 +800 /1 : 25
(RUS)◊ /. . 100 +40 +800 /1 : 10 25
(RUS)◊ /. . 100 +40 +800 /1 : 10
(BLR)◊ /. . 100 +40 +800 /1 : 25
- (RUS)◊ /. . 100 +40 +800 /1 : 25 , 30 50
ZENTIVA (CS)◊ /. . 200 /1 ( 100 /1 ): 30
GOEDECKE (DEU)◊ /. . 300 +2.5 +2.5 /1 : 40
HEMOFARM (RS)◊ /. . 300 +2.5 +2.5 /1 : 40
GOEDECKE (DEU)◊ /. . 300 +3 +4 /1 : 40
HEMOFARM (RS)◊ /. . 300 +3 +4 /1 : 40
GOEDECKE (DEU)◊ /. . 500 +2.5 +2.5 /1 : 40
HEMOFARM KONCERN (UGS)◊ /. . 500 +2.5 +2.5 /1 : 40
GOEDECKE (DEU)◊ /. . 500 +3 +4 /1 : 40
HEMOFARM KONCERN (UGS)◊ /. . 500 +3 +4 /1 : 40
- (RUS) /. . 30 +10 /1 : 10
(RUS) /. . 30 +10 /1 : 10
(RUS)◊ - /. . 25 : . 1 .
- (RUS)◊ /. . 5% (50 /1 ): 25
-JADRAN Galenski Laboratorij (HOR)◊ /. . 5% (50 /1 ): 25
- (RUS)◊ /. . 5% (50 /1 ): 25
-JADRAN Galenski Laboratorij (HOR)◊ /. . 5% (50 /1 ): 25
®LEO PHARMACEUTICAL PRODUCTS (DNK)◊ /. . 500 +50 /1 : 15 , 30 60
®LEO PHARMACEUTICAL PRODUCTS (DNK)◊ /. . 50 /1 : 30 100
®LEO Laboratories (IRL)◊ /. . 50 /1 : 30 100
®LEO PHARMACEUTICAL PRODUCTS (DNK)◊ /. . 50 /1 : 30 100
®LEO Laboratories (IRL)◊ /. . 50 /1 : 30 100
®LEO PHARMACEUTICAL PRODUCTS (DNK)◊ - /. . 50 /1 : . 60
®LEO Laboratories (IRL)◊ - /. . 50 /1 : . 60
®PHARMACIA & UPJOHN COMPANY (USA) /. . 1%: 30
- (RUS) 1010 : 1 .
- (RUS) 1010 : 1 .
- (RUS)◊ /. . 5%: 58
(RUS)◊ /. . 5%: 30
-HEMOFARM KONCERN (UGS)◊ /. . 5%: 30
HEMOFARM KONCERN (UGS)◊ /. . 5%: 30
® (RUS)◊ /. . 52 +8.02 /1 : 25, 30 50
®LEK d.d. (SLO)◊ /. . 1%: 50 , 250
GEDEON RICHTER (HUN) /. . 5 +30 /1 : 5
PFIZER (USA)◊ /. . 40%: 57
. .. (RUS)- / . . 12 +60 /1 : . 50
MENTHOLATUM COMPANY (GBR)◊ /. .: 15 , 35 , 67 100
(UKR)◊ /. .: 15 , 35 , 67 100
SCHERING-PLOUGH LABO (BEL) /. . 500 +1 /1 : 15
SCHERING-PLOUGH LABO (BEL) /. . 500 +1 /1 : 15
SCHERING-PLOUGH LABO (BEL)◊ 500 +30 /1 : 30
SCHERING-PLOUGH (FRA)◊ - /. . 500 +20 /1 : .-. 30
Laboratoires GALDERMA (FRA)◊ /. . 0.1%: 30
Laboratoires GALDERMA (FRA)◊ /. . 0.1%: 30
- ()
Dr.THEISS NATURWAREN (DEU)◊ /. .: 50 , 75 100
MERCKLE (DEU)◊ /. . 500 +25 +150 /1 : 50 100
()
()Aqua, aluminum chlorohydrate, propylene glycol, hydroxyethylcellulose
()
() 50
2 ()Aqua, Aluminium Chloride Hexahydrate, Propylene Glycol, Hydroxyethylcellulose
®GlaxoSmithKline Pharmaceuticals (POL)◊ /. . 100 +2 /1 : 55
-/ (), , , , , , Natrasol HHR 250, , , , , , , ,
" " () /. . 2% (20 /1 ): 20
®YAMANOUCHI EUROPE (NID)◊ /. - /. . 1.2 +360 /30 : . .
STIEFEL LABORATORIES (IRELAND) (IRL)◊ /. . 500 +20 /1 : 6 , 25 , 30 , 40 50
STIEFEL LABORATORIES (UK) (GBR)◊ /. . 500 +20 /1 : 6 , 25 , 30 , 40 50
(UKR)◊ /. . 500 +20 /1 : 6 , 25 , 30 , 40 50
®BALKANPHARMA-TROYAN (BLG)◊ /. . 30 +20 /1 : 45
DEUTSCHE HOMOOPATHIE UNION (DEU)◊ /. .: 50
W.SPITZNER ARZNEIMITTEL-FABRIK (DEU)◊ /. .: 50
DEUTSCHE HOMOOPATHIE UNION-ARZNEIMITTEL (DEU)◊ /. .: 50
-- (RUS)◊ /. . 10%: 25
(RUS)◊ 2%: 20
(RUS)◊ - /. . . : . 20
(RUS)◊ /. . 10%: 25
(RUS)◊ - /. . 10%: . 30
(RUS)◊ - /. . 10%: . 30
-- (RUS)◊ - /. . 10%: . 30
(RUS)◊ - /. . 10%: . 30 50
(RUS)◊ - /. . 2%: . 40
(RUS)◊ - /. . 10%: . 40
-- (RUS)◊ - /. . 10%: . 40
(RUS)◊ - /. . 10%: . 25 , 40 80
(RUS)◊ - /. . 2%: . 25 , 40 80
- (RUS)◊ - /. . 10%: . 40
(RUS)◊ - /. . 10%: . 40 , 50 100
(RUS)◊ - /. . 10%: . 40 , 50 100
(RUS)◊ - /. . 10%: . 40 80
- . (RUS)◊ - /. . 10%: . 40
GLENMARK PHARMACEUTICALS (IND) /. . 250 +10 /1 : 15
GLENMARK PHARMACEUTICALS (IND)◊ /. . 250 +10 +1 /1 : 15
®TALLINN PHARMACEUTICAL COMPANY (EST)◊ /. .: 30 50
IROMEDICA (CHE)◊ : . 250
GLENMARK PHARMACEUTICALS (IND)◊ 20 + 10 /1 : . 60
GLENMARK PHARMACEUTICALS (IND)◊ /. . 0.1%: 15
-GLENMARK PHARMACEUTICALS (IND) /. . 1 +10 /1 : 15
SOLVAY PHARMACEUTICALS (FRA)◊ 10 ×10 1.7 /1 2: 5 10 .
SOLVAY PHARMACEUTICALS (FRA)◊ 20 ×20 1.7 /1 2: 5 10 .
®YAMANOUCHI EUROPE (NID)- /. . 0.5%: . 3.5 .
MERZ PHARMA GmbH & Co. (DEU)◊ /. .: 20 50
(RUS) /. . 5 +2 /1 : 15
(RUS) /. . 5 +2 /1 : 15
BOSNALIJEK (BOS)◊ - /. . 2%: . 60 .
GEDEON RICHTER (HUN)◊ /. . 1.02 /1 : 15
GEDEON RICHTER (HUN)- /. . 2.05 /1 : . 10
(RUS): 4000 - 12,0 ; - 1,0 ; - 0,6;
(RUS)◊ 50 :
- (RUS)◊ /. .: 40 , 1
® (RUS)◊ /. .: 40 , 100 1000
-- (RUS)◊ - /. . 5%: . 25
-- (RUS)◊ - /. . 1%: . 25
-- (RUS)◊ - /. . 3%: . 25
(RUS)◊ - /. . 1%: . 25
(RUS)◊ - /. . 3%: . 25
(RUS)◊ - /. . 5%: . 25
(RUS)◊ - /. . 0.25%: . 25
- (RUS)◊ - /. . 0.25%: . 25 40
- (RUS)◊ - /. . 1%: . 25 40
- (RUS)◊ - /. . 3%: . 25 40
- (RUS)◊ - /. . 5%: . 25 40
® (RUS)◊ /. .: 40 , 50 100
- (RUS). /. - /. 64 : . 5 10 .
- (RUS) /. - /. . . 64 : . 5 .
- (RUS) /. - /. . . 64 : . 5 . . (- 0.5% 5 : . 5 .)
- (RUS) /. - /. . . 64 : . 5 . . (- 0,9% 2 : . 5 .)
/ (RUS)◊ 30 +30 /1 : 30 , 35 40 , 25 , 40 , 50 , 100 , 1000 2000
/ -- (RUS)◊ 30 +30 /1 : 25
® 1000A.MENARINI INDUSTRIE FARMACEUTICHE RIUNITE (ITA)◊ /. . 1 ./1 : 30 , 50 100
® 1000A.MENARINI Manufacturing Logistics and Servicer (ITA)◊ /. . 1 ./1 : 30 , 50 100
(RUS). /. - /. 64 : . 5 10 .
(RUS). /. - /. 64 : . 5 10 . . - (- )
(RUS). /. - /. 64 : . 5 10 . . - (- )
PIERRE FABRE MEDICAMENT PRODUCTION (FRA) 0.05%: 30
PIERRE FABRE MEDICAMENT PRODUCTION (FRA)- /. . 0.1%: . 15
® (RUS) /. - // / 1500 : ., . 5 .
® (RUS) /. - // / 3000 : ., . 5 .
® (RUS)◊ /. . 3 .: 5 .
® PHARMACEUTICAL WORKS JELFA (POL) /. . 200 +30 /1 : 15
® PHARMACEUTICAL WORKS JELFA (POL) 200 +30 /1 : 15
HUNGARO-GAL (HUN)◊ /. .: 50
()
CENTRO DE HISTOTERAPIA PLACENTARIA (CB)- /. . 50 /100 : . 120 235
- (RUS)◊ - /. . 2.5 +1 +1 /100 : . 40
(RUS)◊ - /. . 1 +2.5 +1 /100 : . 40
(RUS)◊ - /. . 2.5 +1 +1 /100 : . 40
(RUS)◊ - /. . 2.5 +1 +1 /100 : . 50
-- (RUS)◊ - /. . 2.5 +1 +1 /100 : . 40
(RUS)◊ - /. . 2.5 +1 +1 /100 : . 40
(RUS)◊ /. . 10%: 25
- (RUS)◊ /. . 10%: 25
(RUS)◊ /. . 10%: 25
(RUS)◊ /. . . 10%: 25
- (RUS)◊ /. . 10%: 25
®UNIQUE PHARMACEUTICAL Laboratories (IND)◊ /. . 10 /1 : 30
®J.B. Chemicals & Pharmaceuticals (IND)◊ /. . 10 /1 : 30
PHARMACEUTICAL WORKS JELFA (POL)◊ /. . 10 /1 : 15
PHARMACEUTICAL WORKS JELFA (POL)◊ /. . 10 /1 : 15
GEDEON RICHTER (HUN) /. . 2.5 +20 /1 : 15
-- (RUS)◊ /. . 6.67 +13.33 /100 : 25
Medela, ()
ܨ " . ". 100 ()
- (RUS). /. - /. 64 : . 5 10 .
- (RUS). /. - /. 64 : . 5 10 . . - (- 0.5%)
- (RUS). /. - /. 64 : . 5 10 . . - (- 0.9%)
(RUS)◊ /. .: 30 50
REANAL (HUN)◊ : 50
MedelaMedela, ()
PHARMACEUTICAL WORKS JELFA (POL) 30 +10 /1 : 10
TARCHOMIN PHARMACEUTICAL WORKS POLFA (POL) /. . 300 +100 /55 : .
GEROT PHARMAZEUTIKA (AUT). 10 : 50 .
R.P.SCHERER (DEU). 10 : 50 .
(RUS)◊ /. .: 60
CHAUVIN ANKERPHARM (DEU)◊ /. . 4.63% (6.02 /130 ): . 1 .
AEROPHARM (DEU)◊ /. . 4.63% (6.02 /130 ): . 1 .
- (RUS)◊ /. . 5%: 58
-MERCKLE (DEU)◊ 5%: 35 100
-ratiopharm (DEU)◊ 5%: 35 100
MERZ PHARMA GmbH & Co. (DEU)◊ .: 30 90 .
CIMEX (CHE)◊ .: 30 90 .
®- (RUS)◊ /. . 5%: 25 30
(RUS)◊ 150 50
(RUS)◊ - /. . 5 +50 /100 : . 80
- (RUS)◊ 100 /1 : . 50
(RUS)◊ 100 /1 : . 50
®YAMANOUCHI EUROPE (NID) 10 +3.5 +10 /1 : 15
®YAMANOUCHI EUROPE (NID) 10 +3.5 +10 /1 : 15
SERUMWERK BERNBURG (DEU)◊ /. .: 30 , 50 100 ; 250
, , Foshan Aqua Gel Biotech Co.Ltd ()

, , d-, L-.

Foshan Aqua Gel Biotech Co.Ltd ()

, ,,

Foshan Aqua Gel Biotech Co.Ltd ()

, , , .

TARCHOMIN PHARMACEUTICAL WORKS POLFA (POL) /. . 10 +400 /30 : .
(RUS)◊ /. . 80 +10 +10 /100 : 40
(RUS)◊ /. . 15 +15 /100 : 25 40
DEUTSCHE HOMOOPATHIE UNION-ARZNEIMITTEL (DEU)◊ /. .: 50
(RUS)◊ /. . 5 +10 +50 /100 : 10 , 20 35
TEVA Pharmaceutical Industries (ISR)◊ .: 30 .
TEVA Pharmaceutical Works (HUN)◊ .: 30 .
®PHARMACIA (BEL)◊ - /. . 2%: . 60 .
®PHARMACIA (BEL)◊ - /. . 5%: . 60 .
(RUS)◊ /. .: 10 , 20 35
- MADAUS (DEU)◊ /. . 5 +1 /100 : 40 100
(BLR)◊ : 15 , 500
-CILAG (CHE) 0.05%: 30
(RUS)◊ /. . 0.01%: 35
(RUS)◊ /. . 0.05%: 35
(RUS)◊ /. . 0.1%: 35
®F.Hoffmann-La Roche (CHE). 10 : 30 100 .
®R.P.SCHERER (DEU). 10 : 30 100 .
®F.Hoffmann-La Roche (CHE). 20 : 30 100 .
®R.P.SCHERER (DEU). 20 : 30 100 .
Laboratoires GALDERMA (FRA)◊ /. . 0.75%: 5 , 15 , 30 50
(RUS)◊ /. .: 25
- -- (RUS)◊ /. . 20 +250 /1 : 25
- (RUS)◊ /. . 20 +250 /1 : 25 50
(RUS)
()
() 60
70 " PoiskLekarstv.ru" (RUS):
10 " PoiskLekarstv.ru" (RUS):
MASTELLI (ITA) /. . 80 /25 :
(RUS)- /. .: . 100
ALDO-UNION (SPN)◊ 1% /. .: 50
ALDO-UNION (SPN)◊ 1% /. .: 50 , 500
(RUS)◊ 10%: 25 , 800 , 1000 1800 , 25
-CHEMINOVA INTERNACIONAL (SPN)◊ /. . 0.2%: 70
-CHEMINOVA INTERNACIONAL (SPN)◊ /. 0.2%: 50
- (RUS)◊ /. 0.2%: 50
-CHEMINOVA INTERNACIONAL (SPN)◊ 1%: . 150 1 ; 5 5 .
- (RUS)◊ 1%: . 150 1 ; 5 5 .
INTENDIS (DEU)◊ 20%: 30
INTENDIS MANUFACTURING (ITA)◊ 20%: 30
INTENDIS (DEU)◊ 20%: 30
INTENDIS MANUFACTURING (ITA)◊ 20%: 30
INTENDIS (DEU)◊ /. . 15%: 5 , 30 50
INTENDIS MANUFACTURING (ITA)◊ /. . 15%: 5 , 30 50
INTENDIS (DEU)◊ /. . 15%: 5 , 30 50
INTENDIS MANUFACTURING (ITA)◊ /. . 15%: 5 , 30 50
(RUS)◊ /. . 20%: 25
VALEANT PHARMACEUTICALS SWITZERLAND (CHE)- /. .: . 0.2 1 . . 2
ICN SWITZERLAND (CHE)◊ 4.15 /1 : 20
ICN PHARMACEUTICALS SWITZERLAND (CHE)◊ 4.15 /1 : 20
ICN SWITZERLAND (CHE)◊ 2.07 /1 : 20
ICN PHARMACEUTICALS SWITZERLAND (CHE)◊ 2.07 /1 : 20
-..- ()
- (RUS)◊ - /. . 10%: . 40
- (RUS)◊ - 1.4 /100 : . 50
TALLINN PHARMACEUTICAL COMPANY (EST)◊ /. . 1%: 50 , 800
(RUS) /. . 4 +100 /1 : 25
(RUS)◊ /. .: 30
® SAGMEL, (USA)◊ /. .: 28.4 56.7
(RUS)◊ /. . 3%: 10 15
(RUS)◊ /. . 3%: 15
(RUS)◊ /. . 3%: 15
- (RUS)◊ 3%: 15
® (RUS)◊ /. . 0.05%: 20 30
INTENDIS (DEU) 10 +1 /1 : 15
INTENDIS MANUFACTURING (ITA) 10 +1 /1 : 15
®SCHERING-PLOUGH LABO (BEL)◊ /. . 500 +10 +1 /1 : 15
®SCHERING-PLOUGH FARMA (PORT)◊ /. . 500 +10 +1 /1 : 15 30
(RUS)◊ /. . 1000 /1 : 30
(RUS)◊ /. . 8%: 50 , 100 250
LICHT FAR EAST (S) (SGP)◊ /. . 8%: 50 , 100 250
®BOEHRINGER INGELHEIM INTERNATIONAL (DEU)◊ /. . 4 +25 /1 : 20
®HAUPT PHARMA WOLFRATSHAUSEN (DEU)◊ /. . 4 +25 /1 : 20
KRKA (SLO), , . .
KRKA (SLO), , D-, (Urtica dioica) (Salvia officinalis).
KRKA (SLO) , PT-S ( 1% (Salix alba))
KRKA (SLO) --S ( (Salix alba)), .
PHARMACEUTICAL WORKS JELFA (POL) 250 +5 /1 : 15
-SCHERING-PLOUGH FARMA (PORT)◊ : . 150
® SCHERING-PLOUGH FARMA (PORT)◊ 5 /1 : . 150
® SCHERING-PLOUGH FARMA (PORT)◊ 20 /1 : . 150
(RUS)◊ . /. - /. . 20 : 10 .
(RUS)◊ - /. . . 0.067%: . 10 25
(RUS)◊ . /. - /. . 20 : 10 .
®LEO PHARMACEUTICAL PRODUCTS (DNK) /. . 2%: 15
®LEO Laboratories (IRL) /. . 2%: 15
®LEO PHARMACEUTICAL PRODUCTS (DNK) /. . 2%: 15
®LEO Laboratories (IRL) /. . 2%: 15
® LEO PHARMACEUTICAL PRODUCTS (DNK) /. . 20 +10 /1 : 15
® LEO Laboratories (IRL) /. . 20 +10 /1 : 15
LEO PHARMACEUTICAL PRODUCTS (DNK) /. . 20 +1 /1 : 15
LEO Laboratories (IRL) /. . 20 +1 /1 : 15
® (RUS)◊ /. . 50 +100 /1 : 30
- (RUS) /. . 1 +1 /1 : 15 30
- SCHERING-PLOUGH LABO (BEL)◊ /. . 1 +1 /1 : 15 30
- SCHERING-PLOUGH LABO (BEL)◊ /. . 1 +1 /1 : 15 30
Laboratoires BOIRON (FRA)◊ /. . .: 30
(RUS)◊ . /. . 12.5 /100 : . 125
(RUS)◊ /. . 10%: 25
(RUS)◊ /. . 10%: 30
(RUS)◊ /. . 10%: 25 , 40 50
®-SCHERING-PLOUGH FARMA (PORT) 1 +50 /1 : 15 45
(RUS) /. . 10 ./1 : 10 15
(RUS) /. . 10 ./1 : 15
(RUS) /. . 10 ./1 : 15
- (RUS) /. . . 10 ./1 : 15 30
-- (RUS) /. . 10 ./1 : 10 15
(RUS)◊ /. . .: 15 , 30 50 , . 25 40
® (RUS)◊ /. .: 15 , 20 , 25 , 30 , 35 40
® (RUS)◊ /. .: 10 25